REFERENCES
- Abernethy, D. R., Todd, E. L. & Schwartz, J. B. (1985). Caffeine disposition in obesity. British Journal of Clinical Pharmacology 20, 61–66.
- Anastacio, M., Hoyumpa, J. R. & Schenker, S. (1982). Influence of liver disease on the disposition and elimination of drugs. In Disease of the Liver, eds. Schiss, L. & Shiss, E. R. pp. 709–747. Philadelphia: Lippincott.
- Blanchard, J. & Sawers, S. J. A. (1983). The absolute bioavailability of caffeine in man. European Journal of Clinical Pharmacology, 24, 93–98.
- Bonati, M., Latini, R., Galletti, F., Young, J. F., Tognoni, G. & Garattini, S. (1982). Caffeine disposition after oral doses. Clinical Pharmacology and Therapeutics, 32, 98–106.
- Desmond, P. V., Patwardhan, R. V., Johnson, R. F. & Schenker, S. (1980). Impaired elimination of caffeine in cirrhosis. Digestive Diseases and Sciences, 25, 193–197.
- Harinasuta, T. & Bunnag, D. (1988). The clinical features of malaria. In Malaria: Principles and Practice of Malariology, eds. Wendorfer, W. H. & McGregor, I. pp. 726–727. London: Churchill Livingstone.
- Jansen, P. L. M., Chamuleau, A. F. M., Van Leewen, D. J., Scipper, H. G., Busemann-Sokole, E. & Van Der Heyde, M. N. (1990). Liver regeneration and resolution of liver function after partial hepatectomy in patients with liver tumors. Scandinavian Journal of Gastroenterology, 25, 112–118.
- Joeres, R., Klinker, H., Heuster, H., Epping, J., Zilly, W. & Richter E. (1988). Influence of smoking on caffeine clearance elimination in healthy volunteers and in patients with alcoholic liver disease. Hepatology, 8, 575–579.
- Jost, G., Wahllander, A., Mandach, V. & Preisig, R. (1987). Overnight salivary caffeine clearance: a liver function test suitable for routine use. Hepatology, 7, 338–344.
- Linskov, J. (1982). The quantitative liver function as measured by the galactose elimination capacity. Acta Medica Scandinavica, 212, 295–302.
- McDonagh, J. E., Nathan, V. V., Bonavia, I. C., Moyle, G. R. & Tanner, A. R. (1991). Caffeine clearance by enzyme multiplied immunoassay technique: a simple, inexpensive, and useful indicator of liver function. Gut, 32, 681–684.
- Molyneux, M. E., Looareesuwan, S., Menzies, I. S., Grainger, S. L., Phillips, R. E., Wattanagoon, Y., Thompson, R. P. H. & Warrell, D. A. (1989). Reduced hepatic blood flow and intestinal malabsorption in severe falciparum malaria. American Journal of Tropical Medicine and Hygiene, 40, 470–476.
- Pathwardan, R. V., Desmond, P. V., Johnson, R. F. & Schenker, S. (1980). Impaired elimination of caffeine by oral contraceptive steroids. Journal of Laboratory and Clinical Medicine, 95, 603–608.
- Pukrittayakamee, S., White, N. J., Davis, T. M. E., Looareesuwan, S., Supanaranond, W., Desakorn, V., Chaivisuth, B. & Williamson, D. H. (1992). Hepatic blood flow and metabolism in severe falciparum malaria: clearance of intravenous administered galactose. Clinical Science, 82, 63–70.
- Rall, T. W. (1990). Drugs used in the treatment of asthma. In Goodman and Gilman's the Pharmacological Basis of Therapeutics, eds. Gilman, A. G., Rall, T. W. & Nies, A. S., Tayler, P. pp. 618–630. New York: Pergamon Press.
- Renner, E., Wiethotz, H., Huguenin, P., Arnaud, M. J. & Preisig, R. (1984). Caffeine: a model compound for measuring liver function. Hepatology, 4, 38–46.
- Swinyard, E. A. (1990). Central nervous system stimulants. In Remington's Pharmaceutical Sciences, 18th Edn., eds. Gennaro, A. R., Chase, G. D., Marderosian, A. D., Harvey, S. C., Hussar, D. A., Medwick, T., Rippie, E. G., Schwarts, J. B., Swinyard, E. A. & Zink, G. L. pp. 1132–1134. Philadelphia: Mack.
- Tang-Lieu, D., Williams, R. L. & Rigelman, S. (1983). Disposition of caffeine and its metabolites in man. Journal of Pharmacology and Experimental Therapeutics, 214, 180–185.
- White, N. J., Looareesuwan, S., Warrell, D. A., Warrell, M. J., Bunnag, D. & Harinasuta, T. (1982). Quinine pharmacokinetics and toxicity in cerebral and uncomplicated falciparum malaria. American Journal of Medicine, 73, 564–572.
- Wilkinson, G. R. & Shand, D. G. (1975). A physiological approach to heptic clearance. Clinical Pharmacology and Therapeutics, 18, 377–390.
- World Health Organization (1990). Severe and complicated malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84 (Suppl. 2), 1–65.